Welcome to our dedicated page for Veeva Systems news (Ticker: $VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Systems stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Veeva Systems's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Veeva Systems's position in the market.
Veeva Systems (NYSE: VEEV) has launched Veeva Vault Basics, a new turnkey solution tailored for biotechs, which includes technology, training, and support with zero implementation and maintenance costs.
This offering allows biotechs to swiftly adopt industry-leading Veeva Vault applications, thereby enhancing efficiency, speed, and compliance. Currently, ten biotechs are using Vault Basics, which equips them with tools to manage growth effectively without additional costs.
The solution includes Vault eTMF Basics, Vault QualityDocs and Training Basics, and Vault Submissions and Submissions Archive Basics, providing a comprehensive suite for clinical trials, GxP document management, and regulatory submissions. Vault Basics is now available in North America, with additional offerings expected in 2025.
Veeva Systems (NYSE: VEEV) will release its fiscal 2025 first-quarter financial results on May 30, 2024, after the market closes. A conference call and webcast will be held at 2:00 p.m. PT (5:00 p.m. ET) on the same day to discuss the results. Prepared remarks will be posted on Veeva's investor relations website before the call. A webcast replay will be available on the website after the event.
